Please sign in to follow a disease.
Zapping nerves to breathe easier: tiny trial tests new COPD approach
NCT ID NCT06985628
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This small study tested whether gentle electrical stimulation of the vagus or trigeminal nerve could ease severe breathlessness in people with advanced COPD. Eight participants tried both active and sham stimulation during exercise. The main goal was to see if such a study is even possible, not to prove the treatment works.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Transcutaneous vagal nerve stimulation (tVNS) and transcutaneous electrical nerve stimulation (TENS) devices
- What this could lead to
- If it works, this could point toward a drug-free way to reduce breathlessness during exercise for people with severe COPD.
- What could go wrong
- This is a very small feasibility study with only 8 participants, so results may not apply to everyone. The devices may not provide meaningful relief, and side effects are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
8 people
The number who actually took part.
- Started
-
Nov 2024
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Severe COPD (between FEV1 20-50%, FEV1/FVC \< 0.7, and smoking history of ≥ 10 pack-years, 3rd-4th grade on the dyspnea scale modified Medical Research Council (mMRC), COPD Assessment Test (CAT) score ≥ 10) * Significant chronic dyspnea for at least 6 months * Referred for pulmonary rehabilitation * Physical capability to undergo submaximal constant work rate (CRW) * Ability to comprehend the implications of the procedures and follow-up visits and provide free informed consent Exclusion Criteria: * Presence of concurrent pulmonary restrictive features * Neurological disorders susceptible to be influenced by neurostimulation procedures, including epilepsy, Parkinson's disease, trigeminal neuralgia, dysautonomia, and vagal disorders * Unstable arrhythmias, and other cardiac instabilities * Patients with cardiac pacemakers, defibrillators, or other metal implants * Patients who have undergone pulmonary resection resulting in the absence of pulmonary lobe(s) or complete lung * Other serious dyspneic conditions, such as anemia, heart failure with decreased ejection fraction, or mitochondrial dysfunction * Pregnancy * Active infections * Known reactions or intolerance to tVNS or trigeminal TENS Patients must have no moderate-to-severe exacerbations (defined as an increase in symptoms for more than 3 days requiring corticosteroids or antibiotics, or hospitalisation) for at least one month before the baseline visit and at least one month before the first experimental visit (W0 visit). Participants that were randomized yet experience an exacerbation between the first (at week 0) and second (at week 2) experimental visits will be removed from the trial. \*Abbreviations : COPD : chronic obstructive pulmonary disease FEV1 : Forced Expiratory Volume in one second FVC : Forced vital capacity tVNS : Transcutaneous vagal nerve stimulation TENS : Transcutaneous electrical nerve stimulation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic obstructive pulmonary disease severe are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre hospitalier universitaire de Sherbrooke (CHUS)
Sherbrooke, Quebec, J1H 5H3, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Three oxygen sensors, one question: can site differences flag the sickest breathless patients?
- Can a handheld breathing device and phone app help COPD patients breathe easier?
- Can a video call save a Child's life? emergency triage goes visual
- A simple breath: could guided breathing calm heart failure symptoms?
- Can a touch on the hands ease Asthma's breathlessness and sleeplessness?
- Can a Hand-Based therapy ease COPD's toughest symptoms?